Literature DB >> 24085300

Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.

Taro Saito1, Masashi Yano, Yusei Kawai, Akiko Asada, Mitsuhito Wada, Hirofumi Doi, Shin-ichi Hisanaga.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) is a brain-specific membrane-bound protein kinase that is activated by binding to the p35 or p39 activator. Previous studies have focused on p35-Cdk5, and little is known regarding p39-Cdk5. The lack of functional understanding of p39-Cdk5 is due, in part, to the labile property of p39-Cdk5, which dissociates and loses kinase activity in nonionic detergent conditions. Here we investigated the structural basis for the instability of p39-Cdk5. p39 and p35 contain N-terminal p10 regions and C-terminal Cdk5 activation domains (AD). Although p35 and p39 show higher homology in the C-terminal AD than the N-terminal region, the difference in stability is derived from the C-terminal AD. Based on the crystal structures of the p25 (p35 C-terminal region including AD)-Cdk5 complex, we simulated the three-dimensional structure of the p39 AD-Cdk5 complex and found differences in the hydrogen bond network between Cdk5 and its activators. Three amino acids of p35, Asp-259, Asn-266, and Ser-270, which are involved in hydrogen bond formation with Cdk5, are changed to Gln, Gln, and Pro in p39. Because these three amino acids in p39 do not participate in hydrogen bond formation, we predicted that the number of hydrogen bonds between p39 and Cdk5 was reduced compared with p35 and Cdk5. Using substitution mutants, we experimentally validated that the difference in the hydrogen bond network contributes to the different properties between Cdk5 and its activators.

Entities:  

Keywords:  CDK (Cyclin-dependent Kinase); Cdk5; Computer Modeling; Cyclins; Hydrogen Bond; Neurons; Serine-Threonine Protein Kinase; Subunit Interaction; p35; p39

Mesh:

Substances:

Year:  2013        PMID: 24085300      PMCID: PMC3820878          DOI: 10.1074/jbc.M113.512293

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Neurotoxicity induces cleavage of p35 to p25 by calpain.

Authors:  M S Lee; Y T Kwon; M Li; J Peng; R M Friedlander; L H Tsai
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

Review 2.  Recycling the cell cycle: cyclins revisited.

Authors:  Andrew W Murray
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  Cdk5 deregulation in the pathogenesis of Alzheimer's disease.

Authors:  Jonathan C Cruz; Li-Huei Tsai
Journal:  Trends Mol Med       Date:  2004-09       Impact factor: 11.951

4.  Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25.

Authors:  G Kusakawa; T Saito; R Onuki; K Ishiguro; T Kishimoto; S Hisanaga
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

Review 5.  Cdk5: a multifaceted kinase in neurodegenerative diseases.

Authors:  Zelda H Cheung; Nancy Y Ip
Journal:  Trends Cell Biol       Date:  2011-12-20       Impact factor: 20.808

6.  Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.

Authors:  Akiko Asada; Taro Saito; Shin-ichi Hisanaga
Journal:  J Cell Sci       Date:  2012-03-30       Impact factor: 5.285

7.  p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.

Authors:  J Ko; S Humbert; R T Bronson; S Takahashi; A B Kulkarni; E Li; L H Tsai
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

8.  Structure and regulation of the CDK5-p25(nck5a) complex.

Authors:  C Tarricone; R Dhavan; J Peng; L B Areces; L H Tsai; A Musacchio
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

9.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.

Authors:  G N Patrick; L Zukerberg; M Nikolic; S de la Monte; P Dikkes; L H Tsai
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

10.  Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules.

Authors:  Satoru Takahashi; Taro Saito; Shin-ichi Hisanaga; Harish C Pant; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2003-01-20       Impact factor: 5.157

View more
  5 in total

1.  Valproic Acid-Induced Anxiety and Depression Behaviors are Ameliorated in p39 Cdk5 Activator-Deficient Mice.

Authors:  Miyuki Takahashi; Toshiyuki Takasugi; Arisa Kawakami; Ran Wei; Kanae Ando; Toshio Ohshima; Shin-Ichi Hisanaga
Journal:  Neurochem Res       Date:  2022-06-08       Impact factor: 4.414

2.  Protocols for Characterization of Cdk5 Kinase Activity.

Authors:  Anita Terse; Niranjana Amin; Bradford Hall; Manju Bhaskar; Binukumar B K; Elias Utreras; Tej K Pareek; Harish Pant; Ashok B Kulkarni
Journal:  Curr Protoc       Date:  2021-10

3.  Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.

Authors:  Hiroyuki Kobayashi; Taro Saito; Ko Sato; Kotaro Furusawa; Tomohisa Hosokawa; Koji Tsutsumi; Akiko Asada; Shinji Kamada; Toshio Ohshima; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

4.  Ubiquitin ligase activity inhibits Cdk5 to control axon termination.

Authors:  Muriel Desbois; Karla J Opperman; Jonathan Amezquita; Gabriel Gaglio; Oliver Crawley; Brock Grill
Journal:  PLoS Genet       Date:  2022-04-14       Impact factor: 5.917

5.  Peripheral and orofacial pain sensation is unaffected by the loss of p39.

Authors:  Michaela Prochazkova; Bradford Hall; Minghan Hu; Tracy Okine; Jennifer Reukauf; B K Binukumar; Niranjana D Amin; Eva Roque; Harish C Pant; Ashok Kulkarni
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.